Digestive & Intestinal Remedies (Pharmacies) - Western Asia

  • Western Asia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$0.45bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.72%, resulting in a market volume of US$0.49bn by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.03 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Western Asia is experiencing significant growth and development. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Western Asia are shifting towards natural and herbal remedies. Consumers are increasingly seeking products that are gentle on their digestive systems and offer long-term benefits. This preference for natural remedies is driven by a growing awareness of the potential side effects of conventional medications and a desire for more holistic approaches to healthcare. Trends in the market include the rise of e-commerce and online pharmacies. Western Asia has seen a rapid increase in internet penetration and smartphone usage, which has led to the popularity of online shopping. Consumers are now able to conveniently purchase Digestive & Intestinal Remedies from the comfort of their homes, leading to the growth of online pharmacies. This trend is expected to continue as more consumers embrace the convenience and accessibility of online shopping. Another trend in the market is the increasing demand for probiotics and digestive enzymes. Probiotics are live microorganisms that provide health benefits when consumed, while digestive enzymes help break down food and aid in digestion. These products are gaining popularity among consumers who are looking for natural ways to improve their digestive health. The growing awareness of the importance of gut health and its impact on overall well-being is driving the demand for probiotics and digestive enzymes. Local special circumstances in Western Asia, such as the prevalence of spicy and rich foods in the regional cuisine, contribute to the high demand for Digestive & Intestinal Remedies. Spicy and rich foods can often lead to digestive discomfort, and consumers in Western Asia are seeking remedies to alleviate these symptoms. The cultural preference for flavorful and indulgent foods has created a niche market for Digestive & Intestinal Remedies that specifically target these issues. Underlying macroeconomic factors, such as increasing disposable incomes and urbanization, are also driving the growth of the Digestive & Intestinal Remedies market in Western Asia. As incomes rise and more people move to urban areas, there is a greater focus on health and well-being. Consumers are willing to spend more on products that promote digestive health and alleviate discomfort. Additionally, the growing middle class in Western Asia has more purchasing power and is increasingly seeking out healthcare products and services. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Western Asia is developing due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, the rise of e-commerce, the demand for probiotics and digestive enzymes, the prevalence of spicy and rich foods, and increasing disposable incomes and urbanization are all contributing to the growth and development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)